About
Technology
Issues
FAQ
Links
Official Page
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.